In vitro biocompatibility study of EDC/NHS cross-linked silk fibroin scaffold with olfactory ensheathing cells
Source abstract
Abstract
In this paper, we investigated silk fibroin (SF) cross-linked by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) and its biocompatibility with olfactory ensheathing cells (OECs). After cross-linked with different concentrations of EDC/NHS solutions, SF scaffolds were analyzed by different techniques such as scanning electron microscopy, Fourier transform infrared spectra, x-ray diffraction, tensile machine and water contact angle assay. As to their structures, we found 4.5% EDC/NHS cross-linked SF possessed a more significant increase of β-sheet and a decrease of α-helix than 1.5% group. These changes helped SF achieve excellent mechanical properties. While more remarkable improvement of hydrophilicity was seen in 1.5% EDC/NHS treated SF. Immunofluorescence, MTT, Annexin-V/PI and ELISA analysis were then conducted to determine the states and functions of OECs on the scaffolds. OECs on 4.5% EDC/NHS cross-linked SF seemed insufficient to spread, and the proliferation was limited on 4 and 6 days. Moreover, 4.5% EDC/NHS exerted adverse effects on cell survival and nerve growth factor (NGF) secretion at day 4, but not 1.5% EDC/NHS. Taken together, SF scaffolds showed improved physical and hydrophilic properties through cross-linking. 1.5% EDC/NHS cross-linked SF scaffolds showed significant advantages between mechanical property and the states and functions with OECs, which has the potential to be used for neural repairing.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Silk-based biomaterials and applications · Nerve injury and regeneration · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Second Department of Orthopaedics, Haining People’s Hospital, Haining, Zhejiang, China
Department of Orthopedics, The Second Hospital of Jingzhou, Jingzhou, Hubei, China
Department of Orthopedics, Yongding Hospital, Suzhou, Jiangsu, China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province
References (46)
Show source-provided references
1. 10.34297/AJBSR.2019.06.00101510.34297/AJBSR.2019.06.001015 ↗
2. 10.1038/s41419-019-1887-410.1038/s41419-019-1887-4 ↗
3. 10.26599/JNR.2019.904002410.26599/JNR.2019.9040024 ↗
4. 10.1016/j.jchemneu.2019.10172810.1016/j.jchemneu.2019.101728 ↗
5. 10.1038/ncpneuro044710.1038/ncpneuro0447 ↗
6. 10.1002/glia.2328210.1002/glia.23282 ↗
7. Gilmour A · J Neurotrauma · 2020 · 66 · 1267
8. 10.1038/s41578-018-0027-610.1038/s41578-018-0027-6 ↗
9. Wu P · Exp Ther Med · 2019 · 17 · 123
10. 10.1515/gps-2021-003810.1515/gps-2021-0038 ↗
11. 10.3390/pharmaceutics1303042910.3390/pharmaceutics13030429 ↗
12. 10.1002/adma.20170108910.1002/adma.201701089 ↗
13. 10.1002/adma.20160547110.1002/adma.201605471 ↗
14. 10.1016/j.ijbiomac.2017.08.18410.1016/j.ijbiomac.2017.08.184 ↗
15. 10.1007/s12010-019-03147-210.1007/s12010-019-03147-2 ↗
16. 10.1007/s10561-019-09790-710.1007/s10561-019-09790-7 ↗
17. 10.3889/oamjms.2018.32210.3889/oamjms.2018.322 ↗
18. 10.1002/bip.2323210.1002/bip.23232 ↗
19. 10.1016/j.actbio.2016.11.05910.1016/j.actbio.2016.11.059 ↗
20. 10.1016/j.actbio.2013.04.01410.1016/j.actbio.2013.04.014 ↗
21. 10.1016/j.msec.2016.01.00110.1016/j.msec.2016.01.001 ↗
22. 10.1016/j.colsurfb.2011.10.00210.1016/j.colsurfb.2011.10.002 ↗
23. 10.1039/C8RA03266A10.1039/C8RA03266A ↗
24. 10.1016/j.ijbiomac.2018.11.02910.1016/j.ijbiomac.2018.11.029 ↗
25. 10.1021/la500426910.1021/la5004269 ↗
26. 10.1016/j.ijbiomac.2018.12.12510.1016/j.ijbiomac.2018.12.125 ↗
27. 10.1242/dev.14831210.1242/dev.148312 ↗
28. 10.1038/s41598-017-18754-410.1038/s41598-017-18754-4 ↗
29. 10.1371/journal.pbio.100246810.1371/journal.pbio.1002468 ↗
30. 10.1523/JNEUROSCI.0085-16.201610.1523/JNEUROSCI.0085-16.2016 ↗
31. 10.1016/j.expneurol.2014.05.00710.1016/j.expneurol.2014.05.007 ↗
32. Yang C · Oxid Med Cell Longev · 2022 · 2022 · 2076680
33. 10.1002/jbm.a.3706610.1002/jbm.a.37066 ↗
34. 10.3727/096368913X67219010.3727/096368913X672190 ↗
35. 10.3727/096368910X49261610.3727/096368910X492616 ↗
36. 10.4028/www.scientific.net/AMR.175-176.22410.4028/www.scientific.net/AMR.175-176.224 ↗
37. 10.1016/j.addr.2012.09.04310.1016/j.addr.2012.09.043 ↗
38. 10.3390/polym1112193310.3390/polym11121933 ↗
39. 10.1021/bm400489210.1021/bm4004892 ↗
40. 10.1016/B978-0-08-100979-6.00003-310.1016/B978-0-08-100979-6.00003-3 ↗
41. 10.1016/j.ijbiomac.2017.08.17310.1016/j.ijbiomac.2017.08.173 ↗
42. 10.1039/C6RA13713J10.1039/C6RA13713J ↗
43. 10.1002/jbm.82029070710.1002/jbm.820290707 ↗
44. 10.2341/13-338-L10.2341/13-338-L ↗
45. Kim MH · Int J Nanomed · 2016 · 11 · 2967
46. 10.1016/j.msec.2016.10.00310.1016/j.msec.2016.10.003 ↗